Its founder, Nicolas Bazan, a 60-year-old neuroscientist, has a seemingly simple and elegant answer to the pain problem: chemically combine a derivative of acetaminophen with a saccharinelike component.

FORBES: Magazine Article

From the looks of it ECRI takes the first principle component of these four variables and then charts the first time derivative.

FORBES: On Lakshum Achuthan and ECRI: This is Becoming Embarrassing for Everyone